Monash University receives major grants from Diabetes Australia
Monash University gets boost from Diabetes Australia Research TrustAs global rates of diabetes escalate, Monash University research projects addressing this urgent health priority have been awarded major grants from Diabetes Australia.
Coinciding with World Diabetes Day on Nov. 14, Diabetes Australia hosted an especial event to announce the largest-ever funding of Australian diabetes research projects.
Among 46 research projects granted funding nationally, totalling $3.5 million, five Monash University projects were awarded grants for Type 1 and 2 diabetes-focused research.
Dr Eliana Marino, from the School of Biomedical Sciences, received $150,000—the largest allocated funding in Victoria—for research focused on understanding the role of diet, gut microbiota and immune system in the development of Type 1 Diabetes.
With diet now a leading cause for the increased incidence of diabetes in Western countries, Dr Marino’s work may lead to new opportunities for the prevention and treatment of Type 1 Diabetes.
“The Diabetes Australia Research Grant will provide me with the support necessary to be competitive in my own right with NHMRC, ARC grants; and will allow me to engage and supervise more students and to generate high-impact publications,” Dr Marino said, adding that for those researchers who work in the field of diabetes as he does, this award represents an honour and an important milestone. “With this success, Monash University is demonstrating one more time to be one of the best science research-intensive universities in Australia.”
Research grants were also awarded to Dr Clinton Bruce, Professor Mark Sleeman and Professor Matthew Watt, of the Department of Physiology, and Dr Jinhua Li, Department of Anatomy and Developmental Biology.
The School of Biomedical Sciences is the largest school in the Faculty of Medicine, Nursing and .Health Sciences at Monash University.
Monash talented scientists conduct research in cancer, cardiovascular disease, development and stem cells, drug discovery, immunology and infection, metabolism and obesity, neuroscience and structural biology. In 2012, they published 553 publications and secured $53 million of income from national and international funding agencies.